| Literature DB >> 36005147 |
Petr Kelbich1,2,3, Karel Hrach1,4, Jan Spicka1, Petr Vachata5,6, Tomas Radovnicky5, Eva Hanuljakova1,3, Jan Krejsek2.
Abstract
Laboratory analysis of basic cerebrospinal fluid (CSF) parameters is considered as essential for any CSF evaluation. It can provide rapidly very valuable information about the status of the central nervous system (CNS). Our retrospective study evaluated parameters of basic CSF analysis in cases of either infectious or non-infectious CNS involvement. Neutrophils are effector cells of innate immunity. Predominance of neutrophils was found in 98.2% of patients with purulent inflammation in CNS. Lymphocytes are cellular substrate of adaptive immunity. We found their predominance in 94.8% of patients with multiple sclerosis (MS), 66.7% of patients with tick-borne encephalitis (TBE), 92.2% of patients with neuroborreliosis, 83.3% of patients with inflammatory response with oxidative burst of macrophages in CNS and 75.0% of patients with malignant infiltration of meninges (MIM). The simultaneous assessment of aerobic and anaerobic metabolism in CSF using the coefficient of energy balance (KEB) allows us to specify the type of inflammation in CNS. We found predominantly aerobic metabolism (KEB > 28.0) in 100.0% CSF of patients with normal CSF findings and in 92.8% CSF of patients with MS. Predominant faintly anaerobic metabolism (28.0 > KEB > 20.0) in CSF was found in 71.8% patients with TBE and in 64.7% patients with neuroborreliosis. Strong anaerobic metabolism (KEB < 10.0) was found in the CSF of 99.1% patients with purulent inflammation, 100.0% patients with inflammatory response with oxidative burst of macrophages and in 80.6% patients with MIM. Joint evaluation of basic CSF parameters provides sufficient information about the immune response in the CSF compartment for rapid and reliable diagnosis of CNS involvement.Entities:
Keywords: aspartate aminotransferase; blood-brain barrier; blood-cerebrospinal fluid barrier; cerebrospinal fluid; coefficient of energy balance; cytological-energy analysis
Year: 2022 PMID: 36005147 PMCID: PMC9406567 DOI: 10.3390/cimb44080251
Source DB: PubMed Journal: Curr Issues Mol Biol ISSN: 1467-3037 Impact factor: 2.976
Figure 1Schematic representation of CSF production. BCB: Blood-Cerebrospinal Fluid Barrier; BBB: Blood-Brain Barrier.
A review of CSF analysis in several patients with neuroinfection caused by intracellular bacteria and yeasts.
| Patient 1 | Patient 2 | Patient 3 | Patient 4 | Patient 5 | Patient 6 | |
|---|---|---|---|---|---|---|
| Total protein [mg/L] | 6926.0 | 3240.0 | 3925.0 | 3970.0 | 2060.0 | 3310.0 |
| Leukocytes/1 µL | 15.3 | 78.7 | 180.0 | 159.0 | 209.0 | 156.7 |
| Lymphocytes [%] | 15.0 | 94.5 | 95.8 | 89.0 | 90.0 | 92.0 |
| Monocytes [%] | 81.0 | 3.1 | 1.4 | 8.0 | 10.0 | 4.0 |
| Neutrophils [%] | 4.0 | 2.4 | 2.8 | 3.0 | 0.0 | 4.0 |
| Glucose [mmol/L] | 1.51 | 3.20 | 2.93 | 1.46 | 1.36 | 2.53 |
| Lactate [mmol/L] | 10.85 | 8.42 | 6.37 | 3.86 | 3.60 | 4.12 |
| KEB | −91.34 | −9.36 | −1.13 | −9.59 | −9.65 | 8.69 |
| AST [IU/L] | 256.8 | 16.8 | 37.2 | 10.8 | not tested | 21.6 |
Figure 2CSF total protein concentrations in our patient groups (*: statistically significant).
Figure 3CSF leukocyte counts in our patient groups (*: statistically significant).
Figure 4Percentage of lymphocytes in CSF in our patient groups (*: statistically significant).
Figure 5Percentage of neutrophils in CSF in our patient groups (*: statistically significant).
Figure 6Percentage of monocytes in CSF in our patient groups (*: statistically significant).
Figure 7Distribution of KEB values in subgroups of our patients (*: statistically significant).
Figure 8Catalytic activities of AST in CSF in our patient groups (*: statistically significant).